Editor’s summary There are many types of pediatric brain tumors, but the goal of immunotherapy is shared among them: enabling tumor antigen–specific T cells to kill tumor cells. Here, Raphael et al. report the landscape of T cells among different types of pediatric brain tumors. The authors found that T cell clonality, or the frequency of T cells sharing a T cell receptor (TCR), can inform patient outcomes across tumor types.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Lance
Contact Lance, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack